New Study Reveals How Lung Cancer Evades Targeted Therapy
A breakthrough study reveals how lung cancer cells develop resistance to osimertinib through exosomal communication. The discovery of LUCAT1’s role in stabilizing c-MET opens new avenues for overcoming treatment resistance in EGFR-mutant lung adenocarcinoma.